参考文献/References:
[1]Martin S,Lange K,Haren MT,et al.Members of the Florey Adelaide Male Ageing Study. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men[J].J Urol,2014,191(1):130-137.
[2]Abrams P,Cardozo L,Fall M,et al.Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society[J].Neurourol Urodyn,2002,21(2):167-178.
[3]Oelke M,Bachmann A,Descazeaud A,et al.European Association of Urology. EAU guidelines on the treatment and follow-up of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction[J].Eur Urol,2013,64(1):118-140.
[4]Rassweiler J,Teber D,Kuntz R,et al.Complications of transurethral resection of the prostate (TURP)-incidence,management,and prevention[J].Eur Urol,2006,50(5):969-979.
[5]Russo GI,Kurbatov D,Sansalone S,et al.Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities[J].Urology,2015,86(2):343-348.
[6]McWilliams JP,Kuo MD,Rose SC,et al.Society of Interventional Radiology.Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate[J].J Vasc Interv Radiol,2014,25(9):1349-1351.
[7]Mitchell ME,Waltman AC,Athanasoulis CA,et al.Control of massive prostatic bleeding with angiographic techniques[J].J Urol,1976,115(6):692-695.
[8]Kably I,Pareira K,Chong W,et al.Prostate artery embolization (PAE) in the management of refractory hematuria of prostatic origin secondary to iatrogenic urological trauma: a safe and effective technique[J].Urology,2016(88):218-221.
[9]Kim JI,Dixon RG,Isaacson AJ.Transgluteal Prostatic Artery Embolization[J].J Vasc Interv Radiol,2018,29(1):90-91.
[10]DeMeritt JS,Elmasri FF,Esposito MP,et al.Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostateembolization[J].J Vasc Interv Radiol,2000,11(6):767-770.
[11]Sun F,Sánchez FM,Crisóstomo V,et al.Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment preliminary study in pigs[J].Radiology,2008,246(3):783-789.
[12]Sun F,Sánchez FM,Crisóstomo V,et al.Transarterial prostatic embolization: initial experience in a canine model[J].AJR Am J Roentgenol,2011,197(2):495-501.
[13]Brook OR,Faintuch S,Brook A,et al.Embolization therapy for benign prostatic hyperplasia: Influence of embolization particle size on gland perfusion[J].J Magn Reson Imaging,2013,38(2):380-387.
[14]邱志磊,王荃,徐海滨,等.前列腺动脉栓塞治疗激素诱导犬前列腺增生的有效性研究[J].临床泌尿外科杂志,2017,32(12):958-960.
[15]Clegg EJ.The arterial supply of the human prostate and seminal vesicles[J].J Anat,1955,89(2):209-216.
[16]Bouissou H,Talazac A.Arterial vascularization of the normal and the pathological prostate in French[J].Ann Anat Pathol(Paris),1959,4(1):63-79.
[17]Garcia-Monaco R,Garategui L,KizilevskyN,et al.Human cadaveric specimen study ofthe prostatic arterial anatomy: implicationsfor arterial embolization[J].J Vasc Interv Radiol,2014,25(2):315-322.
[18]Wang MQ,Duan F,Yuan K,et al.Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy[J].Radiology,2017,282(1):271-280.
[19]Antunes AA,Carnevale FC,da Motta Leal Filho JM,et al.Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study[J].Cardiovasc Intervent Radiol,2013,36(4):978-986.
[20]Gao YA,Huang Y,Zhang R,et al.Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial[J].Radiology,2014,270(3):920-928.
[21]Somani BK,HackingN,BryantT,et al.Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH) [J].BJU Int,2014,114(5):639-640.
[22]Wang MQ,Wang Y,Yan JY,et al.Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men≧75 years: a prospective single-center study[J].World J Urol,2016,34(9):1275-1283.
[23]Carnevale FC,Iscaife A,Yoshinaga EM,et al.Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis[J].Cardiovasc Intervent Radiol,2016,39(1):44-52.
[24]Bagla S,Smirniotopoulos JB,Orlando JC,et al.Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization[J].J Vasc Interv Radiol,2015,26(12):1832-1838.
[25]Pisco JM,Bilhim T,Pinheiro LC,et al.Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients[J].J Vasc Interv Radiol,2016,27(8):1115-1122.
[26]Isaacson AJ,Hartman TS,Bagla S,et al.Initial Experience with Balloon-Occlusion Prostatic Artery Embolization[J].J Vasc Interv Radiol,2018,29(1):85-89.
[27]Kisilevzky N,Laudanna Neto C,Cividanes A.Ischemia of the Glans Penis following Prostatic Artery Embolization[J].J Vasc Interv Radiol,2016,27(11):1745-1747.
[28]Kably I,Bleicher D,Narayanan S,et al.Spontaneous Bladder Stone Voiding after Prostatic Artery Embolization[J].J Vasc Interv Radiol,2017,28(11):1611-1613.
[29]Shim SR,Kanhai KJ,Ko YM,et al.Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression[J].J Urol,2017,197(2):465-479.
[30]Maclean D,Harris M,Drake T,et al.Factors Predicting a Good Symptomatic Outcome After Prostate Artery Embolisation (PAE)[J].Cardiovasc Intervent Radiol,2018,41(8):1152-1159.
相似文献/References:
[1]张细初.良性前列腺增生患者手术前后尿动力学检查的应用价值[J].医学信息,2018,31(23):124.[doi:10.3969/j.issn.1006-1959.2018.23.034]
ZHANG Xi-chu.The Value of Urodynamic Examination before and after Operation in Patients with Benign Prostatic Hyperplasia[J].Journal of Medical Information,2018,31(06):124.[doi:10.3969/j.issn.1006-1959.2018.23.034]
[2]孙晓峰.经尿道前列腺钬激光剜除术治疗良性前列腺增生的临床效果[J].医学信息,2019,32(20):108.[doi:10.3969/j.issn.1006-1959.2019.20.031]
SUN Xiao-feng.Clinical Effect of Transurethral Resection of the Prostate and Laser for the Treatment of Benign Prostatic Hyperplasia[J].Journal of Medical Information,2019,32(06):108.[doi:10.3969/j.issn.1006-1959.2019.20.031]
[3]冯友亮.经尿道等离子前列腺剜除术治疗大体积前列腺增生的疗效[J].医学信息,2020,33(01):109.[doi:10.3969/j.issn.1006-1959.2020.01.033]
FENG You-liang.Effect of Transurethral Plasma Kinetic Enucleation of Prostate for Large-volume Prostatic Hyperplasia[J].Journal of Medical Information,2020,33(06):109.[doi:10.3969/j.issn.1006-1959.2020.01.033]
[4]张红生,吴景夫,邓小林,等.经尿道等离子前列腺剜除术对患者血流动力学及血生化指标的影响[J].医学信息,2020,33(05):102.[doi:10.3969/j.issn.1006-1959.2020.05.031]
ZHANG Hong-sheng,WU Jing-fu,DENG Xiao-lin,et al.Effects of Transurethral Plasma Prostatectomy on Hemodynamics and Blood Biochemical Parameters of Patients[J].Journal of Medical Information,2020,33(06):102.[doi:10.3969/j.issn.1006-1959.2020.05.031]
[5]马志远.TURP与TUVP治疗良性前列腺增生的疗效比较[J].医学信息,2020,33(07):115.[doi:10.3969/j.issn.1006-1959.2020.07.035]
MA Zhi-yuan.Comparison of Curative Effect Between TURP and TUVP in the Treatment of Benign Prostatic Hyperplasia[J].Journal of Medical Information,2020,33(06):115.[doi:10.3969/j.issn.1006-1959.2020.07.035]
[6]何 靖,王海洋,肖嘉伍,等.经皮膀胱造瘘输尿管镜钬激光碎石联合TURP在BPH合并膀胱结石中的应用[J].医学信息,2020,33(16):112.[doi:10.3969/j.issn.1006-1959.2020.16.034]
HE Jing,WANG Hai-yang,XIAO Jia-wu,et al.Application of Percutaneous Cystostomy and Ureteroscope Holmium Laser Lithotripsy Combined with TURP in the Treatment of BPH Complicated with Bladder Stones[J].Journal of Medical Information,2020,33(06):112.[doi:10.3969/j.issn.1006-1959.2020.16.034]
[7]罗杰鑫,卢远生,方少伟,等.良性前列腺增生电切术后再行钬激光剜除术的临床效果[J].医学信息,2020,33(24):101.[doi:10.3969/j.issn.1006-1959.2020.24.027]
LUO Jie-xin,LU Yuan-sheng,FANG Shao-wei,et al.Clinical Effect of Holmium Laser Enucleation After Electroresection of Benign Prostatic Hyperplasia[J].Journal of Medical Information,2020,33(06):101.[doi:10.3969/j.issn.1006-1959.2020.24.027]
[8]赵 鹏,杨 妮,胡黄金,等.升降通癃方在良性前列腺增生治疗中的应用[J].医学信息,2021,34(24):147.[doi:10.3969/j.issn.1006-1959.2021.24.038]
[9]吴 洋.不同手术方式治疗良性前列腺增生的效果[J].医学信息,2022,35(03):109.[doi:10.3969/j.issn.1006-1959.2022.03.026]
WU Yang.Effect of Different Surgical Methods in the Treatment of Benign Prostatic Hyperplasia[J].Journal of Medical Information,2022,35(06):109.[doi:10.3969/j.issn.1006-1959.2022.03.026]
[10]孙鹏飞,王华东.前列疏通汤联合非那雄胺治疗良性前列腺增生的临床疗效及对前列腺特异性抗原的影响[J].医学信息,2023,36(14):133.[doi:10.3969/j.issn.1006-1959.2023.14.027]
SUN Peng-fei,WANG Hua-dong.Clinical Effect of Qianlie Shutong Decoction Combined with Finasteride in the Treatment of Benign Prostatic Hyperplasia and its Effect on Prostate Specific Antigen[J].Journal of Medical Information,2023,36(06):133.[doi:10.3969/j.issn.1006-1959.2023.14.027]